Other OTC - Delayed Quote USD

Escalon Medical Corp. (ESMC)

0.2400 0.0000 (0.00%)
At close: April 23 at 9:30 AM EDT
Loading Chart for ESMC
DELL
  • Previous Close 0.2400
  • Open 0.2400
  • Bid --
  • Ask --
  • Day's Range 0.2400 - 0.2400
  • 52 Week Range 0.0700 - 0.3900
  • Volume 2,000
  • Avg. Volume 4,048
  • Market Cap (intraday) 1.78M
  • Beta (5Y Monthly) -0.52
  • PE Ratio (TTM) 4.00
  • EPS (TTM) 0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.

www.escalonmedical.com

38

Full Time Employees

June 30

Fiscal Year Ends

Related News

Performance Overview: ESMC

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ESMC
7.69%
S&P 500
5.84%

1-Year Return

ESMC
242.86%
S&P 500
22.03%

3-Year Return

ESMC
42.86%
S&P 500
20.77%

5-Year Return

ESMC
118.18%
S&P 500
72.46%

Compare To: ESMC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ESMC

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    1.78M

  • Enterprise Value

    2.74M

  • Trailing P/E

    4.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.26

  • Price/Book (mrq)

    1.49

  • Enterprise Value/Revenue

    0.22

  • Enterprise Value/EBITDA

    3.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.54%

  • Return on Assets (ttm)

    9.47%

  • Return on Equity (ttm)

    45.91%

  • Revenue (ttm)

    12.38M

  • Net Income Avi to Common (ttm)

    450.78k

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    390.44k

  • Total Debt/Equity (mrq)

    38.52%

  • Levered Free Cash Flow (ttm)

    -127.25k

Company Insights: ESMC

People Also Watch